Speech by Federal President Dr. Frank-Walter Steinmeier on the occasion of the awarding of the Grand Cross with Star of the Order of Merit of the Federal Republic of Germany to Özlem Türeci and Uğur Şahin on ...

Germany Frank-Walter Steinmeier · Federal President of Germany

22 March 2021 · Awarding of the Grand Cross with Star of the Order of Merit of the Federal Republic of Germany to Özlem Türeci and Uğur Şahin

Context
Steinmeier awarded the Grand Cross of the Order of Merit to BioNTech founders Özlem Türeci and Uğur Şahin on 22 March 2021 for developing the COVID-19 vaccine.
Main themes
MRNA vaccine development, BioNTech and COVID-19, Order of Merit award, international scientific collaboration, Özlem Türeci and Uğur Şahin, pandemic response, scientific courage and innovation, global vaccine distribution, humanity and shared purpose
Duration
~15 min
53rd percentile
Words
1,830
53rd percentile
Sentences
110
67th percentile
Readability
58
84th percentile
Grade
9.2
13th percentile
Syntax
2.94
39th percentile
Vocabulary
2.07
22nd percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 52%45%
  • Ceremonial 31%27%
  • Economic 14%13%
  • Institutional 2%2%
  • Technological 1%1%
  • Geopolitical 0%0%
  • Environmental 0%0%
  • Not in focus 12%

110 sentences in 31 paragraphs

Dear Dr. Türeci, dear Professor Şahin, it has been two and a half years since you drew the attention of the scientific community with a bold prediction: you stated that messenger RNA technology could be used to quickly develop a vaccine in the event of a pandemic.

At that time, both of you had primarily focused your research on cancer treatment. Your company, Biontech, had not yet brought any product to market. And hardly anyone was thinking about a pandemic.

Then the coronavirus spread. And even before it reached Europe, you both launched the "Project Light Speed" to develop a vaccine that would contain the virus and save lives. As early as January of last year, you were working day and night with your colleagues on this. And this was at a time when many people in Germany were still shaking hands, hugging each other, and leading carefree lives.

You both foresaw early on that the virus epidemic in Wuhan could become a pandemic. No, you combined your foresight with knowledge and a spirit of discovery and recognized that the experimental approach of your decades-long research would lead to a vaccine.

You recognized the "possibility before it became obvious." And you indeed developed the urgently needed vaccine at lightning speed. How urgently we all expect this protection from infection is something we particularly feel in these days. Your groundbreaking discovery saves lives, it saves livelihoods, it secures our social, economic, and cultural survival. With every vaccinated person, we can take a small step back toward normalcy, a step toward the life we miss, and toward the people we love.

I am sure: A similarly existential scientific achievement has rarely been honored in this castle!

Dear Dr. Türeci, dear Professor Şahin, you both felt it was your duty to do something. You were convinced that you could do something and therefore had to do it.

There are always reasons to doubt. But you acted: with passion, with scientific ambition, and with dedication. You did far more than just do something. You did the crucial thing!

It was your company, the small, innovative, fast start-up Biontech in Mainz, that developed the groundbreaking invention, the first effective vaccine against Covid-19. And thus, the Biontech lab became for researchers what the legendary parental garage was for IT tinkerers in the 1970s.

Many people around the world refer to your achievement as a "vaccine miracle." You yourselves are described as an impressive founding couple, leading researchers, heroes of knowledge, and even as saviors of the world. Many have tried to appropriate your achievement, to give your discovery a nationality. But a vaccine has no nationality – it is neither German, nor Turkish, nor American. If it shows anything, it is that people are capable of great and greatest things when they work together in freedom and respect for one another, when they dare to create something new and good across political, social, and cultural boundaries, thereby advancing our society. And for that, you are an example for people everywhere in the world! You both have convinced as scientists through your outstanding achievement. And this achievement, the vaccine you developed, is a service to humanity. And that is exactly why we are here today.

Dear Dr. Türeci, dear Professor Şahin, an award ceremony is a very personal matter. With this order, we honor people who have achieved extraordinary things. People like you, whose lives and personalities are entirely absorbed in the task they have set for themselves; for whom life and work – as we see in you – are almost inseparably intertwined. I suspect that for you, this award ceremony is also just a brief, but hopefully very pleasant pause between two laboratory experiments, and I hope you can enjoy the time with us a little.

We are all aware: The discovery and development of the new vaccine, like all scientific knowledge, is never solely based on the achievements of individuals – not even on the achievements of outstanding scientists like you. And you say it again and again yourselves: Discovery and development are the result of an international research community. And especially in globally interconnected science, this word "community" takes on its own wonderful meaning.

Biontech alone currently employs around 2,000 highly qualified employees from more than sixty nations worldwide.

And the mass production of vaccine doses is not the success of a few individual companies, but of a global production community. A cooperation of many companies that compete hard and harder with each other in normal times. Without this network, we would probably not have access to the vaccine in these times.

And the same, I am convinced, applies to the global distribution of vaccines. Because the pandemic does not distinguish between continents, political systems, religions, or income. It threatens us all together, and it can only be overcome together, namely when people in all parts of the world are protected from the virus. The pandemic is only over when it is over everywhere. That is why it is not only a question of solidarity; it is also our well-understood self-interest to ensure fair access to vaccines worldwide.

Dear Dr. Türeci, dear Professor Şahin, successful couples, it is said, look in one direction. You are both united by your passion for medicine. You are passionate about research. Together, you have dedicated yourselves to combating cancer and other serious diseases. As early as the 1990s, you were fascinated by the fact that the body can attack and destroy cancer cells with its own immune defense.

Your idea: Instead of treating the disease with chemotherapy or radiation, the body should fight cancer itself with the help of so-called messenger RNA. Your vision is the development of a tailored therapy against cancer. Who would not want to solve this enormous task? We trust you both to do it!

In this way, you give hope and a future to people suffering from cancer through your scientific research activities. You show what research in Germany and in the world can achieve: overcoming even the most severe diseases and healing what is considered incurable.

Your paths both began at the University of Cologne and the University of Saarland, before you then moved to Mainz with high academic titles. A happy choice for all involved. Today, your lists of awards and academic publications are long, and the Johannes Gutenberg University in Mainz is now an indispensable part of the top tier of vaccine research. "What great things could possibly come from Mainz?" people have derisively called out to you for years, as I recently read in a magazine article. I am sure: Thanks to you, no one will ever ask this question again – not at Harvard, not at Oxford, not in Silicon Valley. And not only Mainz can be proud of that!

The journey from research to entrepreneurship was a long one, and it is still unfortunately exceptional in this country when academic researchers start companies. You need, as you recently said, Ms. Türeci, a healthy "balance of courage and humility" for that.

Before Biontech, you founded your first biopharmaceutical company in 2001. You chose to be researchers and entrepreneurs because you wanted, as you said, for your research to "reach the patient." It was important to you not only to accelerate knowledge transfer but also to shape it. It was not enough for you to conduct a clinical study. You wanted to see what the research results could change and achieve in the real lives of patients. And so, you describe a moment from last year as a personally moving experience when you could actually see and observe the first people at the start of vaccination.

With courage and humility, and with a clear goal in mind, you both put everything on one card, and as entrepreneurs, you indeed took a great risk. Biotechnology is, if I may say so, a high-risk business. One that requires money and patience, and as much of both as possible. Taking high risks when it comes to financial ventures is still not easy in Germany. Yes, there are government funding programs, and your research was also funded. But that may not have been the decisive factor.

What is special is that you tirelessly and for a long time were willing to put everything on the line to make your vision a success. Your courage, your drive, and your trust in success impress me, and I am sure they deeply impress everyone watching here. We need a lot of this courage and drive in our country! Especially when it is difficult, as in these times in which we live.

Of course, there are setbacks in the fight against the pandemic, just this week again, of course, mistakes have also been made. We are not as far along as we wanted to be and as we should be. And yes, there is uncertainty and frustration in our country. I understand that all too well.

But: Right now, especially in the face of the third wave, is not the time for resignation and self-pity! Of course, we need to analyze what has happened, identify mistakes, and address weaknesses. But I believe we are truly wasting a lot of energy searching for the scapegoat of the day. Energy that we as a society urgently need elsewhere at the moment. Because right now, only one thing helps: to vaccinate more and faster – with all the means we have! That is the order of the hour! With courage, with intelligence, with a good deal more pragmatism. In this, perhaps the most difficult phase of the pandemic, the story of the award recipients today can inspire us, can serve as a model in the best sense – for citizens, for politicians, for all those who bear responsibility.

One thing this great couple has shown: We can do it! And Germany can do it! That is why I remain convinced, despite all adversities, and yes, later than hoped – but we will bring the pandemic under control.

"What matters must be said: We can win and live."

I am not a comprehensive expert on contemporary poetry, but I dare to assume that there are not too many immunologists about whom poems are written. But you are among them! "We can win and live," writes the Indian poet and sociologist Surendra Munshi in a poem dedicated to you.

We will probably never be able to completely defeat the coronavirus. But if we pool our strengths, we will get the virus under control and learn to live with it.

Professor Şahin, you recently reminded us that you started with a treatment for cancer for an individual person. And today we have a vaccine for all of humanity.

On behalf of our country, I thank you both for your outstanding scientific achievement. I wish you, and all of us, that your further great research plans will bring equally groundbreaking successes. Not for the sake of winning, but for the sake of life!